ArticleEuropean journal of heart failure2021

Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'.

Thibaud Damy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.